Skip to main content
. 2018 Oct-Dec;34(4):490–495. doi: 10.4103/joacp.JOACP_329_15

Table 3.

Clinical outcomes and adverse events

I-gel insertion time (s) 38±7.8
Traqueal intubation time (s) 36±16
I-gel insertion attempts n(%)
 1 69 (81.1)
 2 16 (18.9)
 3 0 (0)
SpO2 (%) t0 t1 t2 t3
96.9±1.2 99.0±0.9 96.2±2.4 96.0±2.5
 >90 n(%) 85 (100) 85 (100) 82 (96.4) 81 (95.3)
 85-90 n(%) 0 (0) 0 (0) 3 (3.5) 3 (3.5)
 <85 n(%) 0 (0) 0 (0) 0 (0) 1 (1.2)
Cough n(%) 6 (7.1)
Hemodynamic parameters changes n(%)
Heart rate >25% 12 (14.1)
Mean arterial pressure >25% 9 (10.5)
Bispectral index t0 t1 t2 t3
95±3 94±4 75±8 37±5
Bronchospasm 0
Laryngospasm 0
Bleeding 0
Airway injury (lips, teeth, palate, tongue, vocal cords) 0
Sore throat 2
Recall n(%) 11 (12.9)
 Visual analogue score 2 (1-3)

Values refer to mean±SD, n (%) and (IQR). t0=Arrival at operating room; t1=After face mask preoxygenation with 100% O2; t2=After i-gel insertion; t3=After intubation; SD=Standard deviation; IQR=Inter-quartile range